Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.
about
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human HealthAntimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosisDevelopment of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.Normal flora and bacterial vaginosis in pregnancy: an overview.Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant womenHigh-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome.Age-Related 1H NMR Characterization of Cerebrospinal Fluid in Newborn and Young Healthy PigletsNovel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR.Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.Cervicovaginal Fluid Acetate: A Metabolite Marker of Preterm Birth in Symptomatic Pregnant Women.Bioavailability of Microencapsulated Iron from Fortified Bread Assessed Using Piglet Model.Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials.Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis.
P2860
Q26738283-AE2B55B6-E07D-40AA-850A-E73ACE597327Q28081831-A072521F-FB6D-4713-9DE3-14755B5AE7E9Q35385384-96296FB1-E9D5-4CF1-A524-BB6E931A082CQ35592893-E7BE8DE6-F861-414C-A6E7-516F3A36E21BQ35670618-0FCDB3D4-02F9-41DB-A11F-4624803DB4CBQ35781450-9593DD2E-CEAA-4177-8B9F-460DB1CD67CCQ35791181-CA4F51B4-293D-4E35-AE58-25FD1D74F49CQ36071030-AE6968B0-40EF-4B18-939A-F6578E2ECD47Q36282865-1EFCE573-C2CE-4068-A840-A35A99BC1247Q37050178-F16AD7E8-5E02-4377-A50B-FD6539358EDCQ37324317-90A64DB6-A691-49DA-935A-75B1399F8900Q37729811-1E544988-765F-47CC-A027-463E59592BAFQ38851896-29D4DDF5-6F94-4A9E-AA0D-F590B04B6376Q54237349-5FECDA02-6F53-4AAB-86DD-78B44161F830
P2860
Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rifaximin modulates the vagina ...... fected by bacterial vaginosis.
@ast
Rifaximin modulates the vagina ...... fected by bacterial vaginosis.
@en
type
label
Rifaximin modulates the vagina ...... fected by bacterial vaginosis.
@ast
Rifaximin modulates the vagina ...... fected by bacterial vaginosis.
@en
prefLabel
Rifaximin modulates the vagina ...... fected by bacterial vaginosis.
@ast
Rifaximin modulates the vagina ...... fected by bacterial vaginosis.
@en
P2093
P2860
P50
P356
P1476
Rifaximin modulates the vagina ...... fected by bacterial vaginosis.
@en
P2093
Beatrice Vitali
Federica Cruciani
Fiorella Calanni
P2860
P304
P356
10.1128/AAC.02469-14
P407
P577
2014-04-07T00:00:00Z